| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.4 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.05 | 0.4 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |